Amifampridine Phosphate: A Thorough QTc study

• Research type

  Research Study

• Full title

  A Phase 1, Double-Blind, Randomized, Crossover Study to Define the ECG Effects of Amifampridine Phosphate Using a Therapeutic and a Supratherapeutic Dose Compared to Placebo and Moxifloxacin (a Positive Control) in Healthy Men and Women Who Are Slow Acetylators: A Thorough QT Study

• IRAS ID

  123924

• Contact name

  Joseph Chiesa

• Contact email

  joseph.chiesa@covance.com

• Sponsor organisation

  BioMarin Pharmaceuticals Inc

• Eudract number

  2011-005306-29

• ISRCTN Number

  N/A

• Clinicaltrials.gov Identifier

  N/A

• REC name

  South Central - Berkshire B Research Ethics Committee

• REC reference

  13/SC/0193

• Date of REC Opinion

  7 May 2013

• REC opinion

  Further Information Favourable Opinion